CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Eli Lilly and Company v. Genentech, Inc.

2:13-cv-07248

Overview

Case Number 2:13-cv-07248
Filing Date 2013-10-01
Status Terminated
Termination Date 2015-04-06
Court District Court, C.D. California (cacd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:2201 Declaratory Judgment
Jury Demand Both

Parties

Defendant

Counter Defendant

Third Party Plaintiff

Genentech, Inc. Operating Company

Represented By

11 Attorneys Listed

City of Hope NPE (Individual / Inventor)

Represented By

10 Attorneys Listed

Court & Judges

Court

District Court, C.D. California (cacd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 8 proceedings
🏛️
USPTO PTAB Trials 6 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (14 found):
PTAB: 6 U.S. Courts: 8
USPTO PTAB Trial 2016-10-11
IPR2017-00047

Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-07-07
IPR2016-01373

Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2016-03-03
IPR2016-00710

Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-01-15
IPR2016-00460

Genzyme Corporation et al. v. GENENTECH, INC. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2015-12-30
IPR2016-00383

GENZYME CORPORATION et al. v. Genentech Inc. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2015-07-27
IPR2015-01624

Sanofi-Aventis U.S. LLC et al. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2019-04-05
1:19-cv-00638

Genentech, Inc. v. Pfizer Inc.

Asserted Patent
Status: DED
U.S. District Court 2019-03-29
1:19-cv-00602

Genentech, Inc. v. Immunex Rhode Island Corp.

Asserted Patent
Status: DED
U.S. District Court 2018-09-04
1:18-cv-01363

Genentech, Inc. v. Samsung Bioepis Co., Ltd.

Asserted Patent
Status: DED
U.S. District Court 2018-07-11
1:18-cv-11553

GENENTECH, INC. v. CELLTRION, INC.

Asserted Patent
Status: NJD
U.S. District Court 2018-01-12
1:18-cv-00095

Genentech, Inc. v. Celltrion, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-18
1:17-cv-01471

Genentech, Inc. v. Amgen, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-06
1:17-cv-01407

Genentech, Inc. v. Amgen Inc.

Asserted Patent
Status: DED
U.S. District Court 2010-04-15
2:10-cv-02764

Glaxo Group Limited v. Genentech, Inc.

Asserted Patent
Status: CACD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6331415
Filed: —
Issued: —
Term Verification Pending
Expires: —

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

119

Dispositive

73

Granted

23

Denied

6

Pending / Review

90

Motions by Category

Procedural / Extension Motion 7 Motion to Dismiss 17 Motion to Transfer Venue (28 U.S.C. § 1404) 2 Claim Construction / Markman Filing 22 Motion to Compel Discovery 17 Motion for Summary Judgment (Rule 56) 6 Motion for Summary Judgment (Invalidity) 48

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Invalidity) Denied
ORDER DENYING PLAINTIFFS MOTION FOR SUMMARY JUDGMENT ON DOUBLE PATENTING by Judge Mariana R. Pfaelzer: 294 . The Court finds Eli Lillys other arguments unpersua...
Entry #382 • 2015-03-05 Document →
Motion for Summary Judgment (Rule 56) Granted
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE UNDER SEAL DOCUMENTS IN CONNECTION WITH PLAINTIFFS MOTION FOR SUMMARY JUDGMENT by Judge Mariana R. Pfaelzer: The C...
Entry #379 • 2015-03-04 Document →
Motion for Summary Judgment (Invalidity) Granted
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE UNDER SEAL DOCUMENTS IN CONNECTION WITH LILLYS MOTION FOR SUMMARY JUDGMENT OF INVALIDITY OF ALL ASSERTED CLAIMS OF...
Entry #381 • 2015-03-04 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
ORDER RE: APPLICATION TO FILE UNDER SEAL DOCUMENTS FILED IN CONNECTION WITH GENENTECH, INC. AND CITY OF HOPES OPPOSITIONS TO LILLYS MOTIONS FOR SUMMARY JUDGMENT...
Entry #384 • 2015-03-04 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
SEALED DOCUMENT-EXHIBIT D, E, H K, M, N AND S TO THE DECLARATION OF ADAM R BRAUSA IN SUPPORT OF GENENTECH INC AND CITY OF HOPE'S OPPOSITION TO LILLY'S to MOTION...
Entry #387 • 2015-03-04 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
SEALED DOCUMENT-STATEMENT of STATEMENT OF GENUINE ISSUES IN SUPPORT OF GENENTECH, INC. AND CITY OF HOPE'S OPPOSITION TO PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT ...
Entry #389 • 2015-03-04 Document →

Docket Entries

(392 total)
Pleading / Complaint

COMPLAINT FOR DECLARATORY JUDGMENT OF INVALIDITY, UNENFORCEABILITY, AND NONINFRINGEMENT; DEMAND FOR JURY TRIAL; against City of Hope, Genentech, Inc. ( Filing fee $ 350.00, receipt number 54611013281.). Filed byImclone Systems LLC, Eli Lilly and Company. (gmS, ) (Filed on 2/28/2013) (Additional attachment(s) added on 3/1/2013: # 1 Exhibits A-B, # 2 Exhibits C-E, # 3 Civil Cover Sheet) (jlm, COURT STAFF). [Transferred from California Northern on 10/1/2013.] (Entered: 02/28/2013)

Entry #1 • 2013-02-28
1

Certificate of Interested Entities by Eli Lilly and Company, Imclone Systems LLC (gmS, ) (Filed on 2/28/2013) (jlm, COURT STAFF). [Transferred from California Northern on 10/1/2013.] (Entered: 02/28/2013)

Entry #2 • 2013-02-28
1

Plaintiffs Statement by Eli Lilly and Company, Imclone Systems LLC. (gmS, ) (Filed on 2/28/2013) (jlm, COURT STAFF). [Transferred from California Northern on 10/1/2013.] (Entered: 02/28/2013)

Entry #3 • 2013-02-28
1

Summons Issued as to City of Hope. (gmS, ) (Filed on 2/28/2013) (jlm, COURT STAFF). [Transferred from California Northern on 10/1/2013.] (Entered: 02/28/2013)

Entry #4 • 2013-02-28
1

Summons Issued as to Genentech, Inc.. (gmS, ) (Filed on 2/28/2013) (jlm, COURT STAFF). [Transferred from California Northern on 10/1/2013.] (Entered: 02/28/2013)

Entry #5 • 2013-02-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc